Angiosarcoma of the heart: Case report and review of the literature

Anticancer Research

Volumn 26, Issue 6 C, 2006, Pages 4837-4842

  Batzios, S ^a   Michalopoulos, A ^a   Kaklamanis, L ^b   Stathopoulos, J ^a   Christopoulou, M ^a   Koutantos, J ^a   Stathopoulos, G P ^a,c  

^a Errikos Dunant Hospital   (Greece)

^b Onasio Hospital   (Greece)

^c NONE   (Greece)

Author keywords

Angiosarcoma; c erb B2; c hit; Glivec; Heart; Herceptin

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; IFOSFAMIDE; IMATINIB; MESNA; STEM CELL FACTOR RECEPTOR; TRASTUZUMAB;

ADULT; ANGIOSARCOMA; ARTICLE; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HEART SARCOMA; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MEDICAL LITERATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR BIOPSY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CISPLATIN; EPIRUBICIN; FEMALE; HEART NEOPLASMS; HEMANGIOSARCOMA; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS;

EID: 33845953240     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Fernandex F, Soufen HN and Ianni BM: Primary neoplasms of the heart. Clinical and histological presentation of 50 cases. Arq Bras Cardiol 76(3): 231-237, 2001.
2. Burke AP, Cowan D and Virmani R: Primary sarcomas of the heart. Cancer 69(2): 387-195, 1992.
3. Rettmar K, Stierle U, Sheikhzadeh A and Diederich KW: Primary angiosarcoma of the heart. Report of a case and review of the literature. Jpn Heart J 35(5): 667-683, 1993.
4. Tazelaar HD, Locke TJ and McGregor CG: Pathology of surgically-excised primary cardiac tumors. Mayo Clin Proc 67(10): 957-965, 1992.
5. Hermann MA, Shankerman RA and Edwards WD: Primary cardiac angiosarcoma: a clinicopathologic study of six cases. J Thorac Cardiovasc Surg 103(4): 655-664,1992.
6. Kirova YM, Feuilhade F, Calitchi E, Otmezguine Y and Le Bourgeois JP: Stewart-Treves syndrome after treatment for breast cancer. Breast 8(5): 282-284, 1999.
7. Zu Y, Perle MA and Yan Z: Chromosomal abnormalities and p53 gene mutation in a cardiac angiosarcoma. Appl Immunohistochem Mol Morphol 9(1): 24-28, 2001.
8. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS and Little JB: Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52: 6194-6199, 1992.
9. Duda RB, Cundiff D, August CZ, Wagman LD and Bauer KD: Growth factor receptor and related oncogene determinations in mesenchymal tumors. Cancer 71(11): 3526-3530, 1993.
10. Kosuga T, Fukunaga S and Kawara T: Surgery for primary cardiac tumors. Clinical experience and surgical results in 60 patients. J Cardiovasc Surg (Torino) 43(5): 581-587, 2002.
11. Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 350: 1647-1654, 1997.
12. Uberfuhr R, Meiser B and Fuchs A: Heart transplantation: an approach to treating primary cardiac sarcoma? J Heart Lung Transplant 21(10): 1135-1139, 2002.
13. Raaf HN and Raaf JH: Sarcomas related to the heart and vasculature. Semin Surg Oncol 10(5): 374-382, 1994.
14. Tsukasa NI, Toyoki F and Takaaki S: Primary cardiac angiosarcoma: 53 months' survival after multidisciplinary therapy. Ann Thorac Surg 63: 1160-1161, 1997.
15. Keohan ML and Taub RN: Chemotherapy for advanced sarcoma: therapeutic decisions and modalities. Semin Oncol 24(5): 572-279, 1997.
16. Kolb EA, Kushner BH, Gorlick R, Laverdiere D, Healey JH, LaQuaglia MP, Huvos AG, Qin J, Vu HT, Weyler L, Wolden S and Meyers PA: Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol 21: 3423-3430, 2003.
17. Fata R, O'Reilly E, Ilson D, Phister D, Leffel D, Kelson DP, Schwartz GK and Casper ES: Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 86: 2034-2037, 1999.
18. Hayes AJ, Mostyn-Jones A, Koban MU, A'Hern R, Burton P and Thomas JM: Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma. Br J Surg 91: 242-247, 2004.
19. Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL, Steinberg SM, Chen HX and Rosenberg SA: A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody for metastatic renal cancer. N Engl J Med 349: 427-434, 2003.
20. Yamamoto T, Umeda T and Nishioka K: Immunohistological distribution of stem cell factor and kit receptor in angiosarcoma. Acta Derm Venereol 80(6): 443-435, 2000.
21. Miettinen M, Sarlomo-Rikal M and Lasota J: KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Mod Pathol 13(5): 536-541, 2000.